Dec 04, 2020 / 05:00PM GMT
Operator
Good morning, and welcome to the EyePoint Pharmaceuticals' Key Opinion Leader Virtual Roundtable on the Future of Drug Delivery for Wet AMD. (Operator Instructions) Please note, this event is being recorded.
I would now like to turn the conference over to Nancy Lurker, President and Chief Executive Officer of EyePoint Pharmaceuticals. Please go ahead.
Nancy S. Lurker - EyePoint Pharmaceuticals, Inc. - President, CEO & Director
Thank you very much, and welcome, everyone. Thank you for joining us today to this important webcast. I think you'll find it very insightful and informative about a very serious eye disease, wet age-related macular degeneration and the treatments that are available and in the pipeline.
Next slide. We are a publicly traded company, and so we will be making forward-looking statements. I urge you to go to our website, where you can review all of our SEC statements.
Next slide. Thank you. Joining us today is a group of very prestigious retinal surgeons. I'm very pleased to welcome them: Dr. Bob Avery; Dr. Elias
EyePoint Pharmaceuticals Inc to Host Key Opinion Leader Virtual Roundtable on the Future of Drug Delivery for Wet AMD Transcript
Dec 04, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers